Annual SG&A
$87.54 M
-$14.74 M-14.41%
31 December 2023
Summary:
Standard BioTools annual selling, general & administrative expenses is currently $87.54 million, with the most recent change of -$14.74 million (-14.41%) on 31 December 2023. During the last 3 years, it has fallen by -$10.36 million (-10.58%). LAB annual SG&A is now -14.41% below its all-time high of $102.28 million, reached on 31 December 2022.LAB Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$34.40 M
-$3.27 M-8.68%
30 September 2024
Summary:
Standard BioTools quarterly selling, general & administrative expenses is currently $34.40 million, with the most recent change of -$3.27 million (-8.68%) on 30 September 2024. Over the past year, it has increased by +$12.11 million (+54.33%). LAB quarterly SG&A is now -26.71% below its all-time high of $46.94 million, reached on 31 March 2024.LAB Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$4.36 B
-$170.60 M-4.08%
30 September 2024
Summary:
Standard BioTools TTM selling, general & administrative expenses is currently -$4.36 billion, with the most recent change of -$170.60 million (-4.08%) on 30 September 2024. Over the past year, it has dropped by -$4.44 billion (-5140.90%). LAB TTM SG&A is now -3155.58% below its all-time high of $140.37 million, reached on 30 September 2024.LAB TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LAB Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -14.4% | +54.3% | -5140.9% |
| 3 y3 years | -10.6% | +42.9% | -4138.4% |
| 5 y5 years | +9.7% | +83.1% | -5256.3% |
LAB Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -14.4% | at low | -26.7% | +70.1% | -54.9% | at low |
| 5 y | 5 years | -14.4% | +9.7% | -26.7% | +83.1% | -80.2% | at low |
| alltime | all time | -14.4% | +802.6% | -26.7% | +553.8% | -3155.6% | at low |
Standard BioTools Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $34.40 M(-8.7%) | $140.37 M(+9.4%) |
| June 2024 | - | $37.67 M(-19.7%) | $128.26 M(+13.3%) |
| Mar 2024 | - | $46.94 M(+119.8%) | $113.19 M(+29.3%) |
| Dec 2023 | $87.54 M(-14.4%) | $21.35 M(-4.2%) | $87.54 M(+1.3%) |
| Sept 2023 | - | $22.29 M(-1.4%) | $86.41 M(-4.5%) |
| June 2023 | - | $22.60 M(+6.1%) | $90.46 M(-7.6%) |
| Mar 2023 | - | $21.30 M(+5.3%) | $97.94 M(-8.9%) |
| Dec 2022 | $102.28 M(+3.4%) | $20.22 M(-23.2%) | $107.52 M(-2.5%) |
| Sept 2022 | - | $26.34 M(-12.4%) | $110.26 M(+2.1%) |
| June 2022 | - | $30.08 M(-2.6%) | $107.99 M(+5.7%) |
| Mar 2022 | - | $30.88 M(+34.5%) | $102.16 M(+3.3%) |
| Dec 2021 | $98.89 M(+1.0%) | $22.96 M(-4.6%) | $98.89 M(-8.3%) |
| Sept 2021 | - | $24.07 M(-0.7%) | $107.86 M(+1.3%) |
| June 2021 | - | $24.25 M(-12.2%) | $106.45 M(+3.5%) |
| Mar 2021 | - | $27.61 M(-13.5%) | $102.81 M(+5.0%) |
| Dec 2020 | $97.90 M(+15.9%) | - | - |
| Dec 2020 | - | $31.93 M(+41.0%) | $97.90 M(+15.5%) |
| Sept 2020 | - | $22.66 M(+9.9%) | $84.76 M(+2.3%) |
| June 2020 | - | $20.62 M(-9.2%) | $82.83 M(-1.8%) |
| Mar 2020 | - | $22.70 M(+20.8%) | $84.35 M(-0.2%) |
| Dec 2019 | $84.48 M(+5.9%) | - | - |
| Dec 2019 | - | $18.79 M(-9.3%) | $84.48 M(-3.6%) |
| Sept 2019 | - | $20.73 M(-6.3%) | $87.66 M(+0.8%) |
| June 2019 | - | $22.13 M(-3.0%) | $86.95 M(+3.8%) |
| Mar 2019 | - | $22.82 M(+3.9%) | $83.80 M(+5.0%) |
| Dec 2018 | $79.78 M(+0.3%) | $21.97 M(+9.7%) | $79.78 M(+8.3%) |
| Sept 2018 | - | $20.02 M(+5.4%) | $73.67 M(-0.1%) |
| June 2018 | - | $18.99 M(+1.0%) | $73.76 M(-2.6%) |
| Mar 2018 | - | $18.80 M(+18.5%) | $75.75 M(-4.7%) |
| Dec 2017 | $79.52 M | $15.86 M(-21.1%) | $79.52 M(-8.0%) |
| Sept 2017 | - | $20.10 M(-4.2%) | $86.42 M(-1.2%) |
| June 2017 | - | $20.98 M(-7.1%) | $87.44 M(-3.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2017 | - | $22.58 M(-0.8%) | $90.31 M(-3.1%) |
| Dec 2016 | $93.21 M(+12.4%) | $22.77 M(+7.8%) | $93.21 M(+0.7%) |
| Sept 2016 | - | $21.12 M(-11.4%) | $92.53 M(+1.7%) |
| June 2016 | - | $23.84 M(-6.4%) | $90.96 M(+3.0%) |
| Mar 2016 | - | $25.48 M(+15.3%) | $88.34 M(+6.5%) |
| Dec 2015 | $82.96 M(+16.3%) | $22.09 M(+12.9%) | $82.96 M(+4.1%) |
| Sept 2015 | - | $19.56 M(-7.8%) | $79.71 M(+1.2%) |
| June 2015 | - | $21.22 M(+5.6%) | $78.73 M(+3.4%) |
| Mar 2015 | - | $20.09 M(+6.7%) | $76.16 M(+6.8%) |
| Dec 2014 | $71.32 M(+47.3%) | $18.84 M(+1.4%) | $71.32 M(+8.0%) |
| Sept 2014 | - | $18.57 M(-0.4%) | $66.06 M(+10.9%) |
| June 2014 | - | $18.66 M(+22.3%) | $59.58 M(+13.4%) |
| Mar 2014 | - | $15.26 M(+12.4%) | $52.52 M(+8.5%) |
| Dec 2013 | $48.41 M(+25.8%) | $13.57 M(+12.2%) | $48.41 M(+6.7%) |
| Sept 2013 | - | $12.10 M(+4.3%) | $45.39 M(+7.1%) |
| June 2013 | - | $11.60 M(+4.0%) | $42.40 M(+5.4%) |
| Mar 2013 | - | $11.15 M(+5.6%) | $40.22 M(+4.5%) |
| Dec 2012 | $38.48 M(+22.9%) | $10.55 M(+15.9%) | $38.48 M(+7.2%) |
| Sept 2012 | - | $9.10 M(-3.4%) | $35.89 M(+3.0%) |
| June 2012 | - | $9.42 M(+0.2%) | $34.84 M(+4.7%) |
| Mar 2012 | - | $9.40 M(+18.0%) | $33.27 M(+6.3%) |
| Dec 2011 | $31.30 M(+33.0%) | $7.97 M(-1.1%) | $31.30 M(+7.2%) |
| Sept 2011 | - | $8.05 M(+2.7%) | $29.21 M(+9.0%) |
| June 2011 | - | $7.84 M(+5.4%) | $26.81 M(+7.8%) |
| Mar 2011 | - | $7.44 M(+26.7%) | $24.87 M(+5.6%) |
| Dec 2010 | $23.55 M(+19.8%) | $5.87 M(+4.0%) | $23.55 M(+2.7%) |
| Sept 2010 | - | $5.65 M(-4.3%) | $22.93 M(+32.7%) |
| June 2010 | - | $5.90 M(-3.6%) | $17.29 M(+51.8%) |
| Mar 2010 | - | $6.12 M(+16.3%) | $11.38 M(+116.3%) |
| Dec 2009 | $19.65 M(-12.7%) | $5.26 M | $5.26 M |
| Dec 2008 | $22.51 M(+74.5%) | - | - |
| Dec 2007 | $12.90 M(+33.0%) | - | - |
| Dec 2006 | $9.70 M | - | - |
FAQ
- What is Standard BioTools annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Standard BioTools?
- What is Standard BioTools annual SG&A year-on-year change?
- What is Standard BioTools quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Standard BioTools?
- What is Standard BioTools quarterly SG&A year-on-year change?
- What is Standard BioTools TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Standard BioTools?
- What is Standard BioTools TTM SG&A year-on-year change?
What is Standard BioTools annual selling, general & administrative expenses?
The current annual SG&A of LAB is $87.54 M
What is the all time high annual SG&A for Standard BioTools?
Standard BioTools all-time high annual selling, general & administrative expenses is $102.28 M
What is Standard BioTools annual SG&A year-on-year change?
Over the past year, LAB annual selling, general & administrative expenses has changed by -$14.74 M (-14.41%)
What is Standard BioTools quarterly selling, general & administrative expenses?
The current quarterly SG&A of LAB is $34.40 M
What is the all time high quarterly SG&A for Standard BioTools?
Standard BioTools all-time high quarterly selling, general & administrative expenses is $46.94 M
What is Standard BioTools quarterly SG&A year-on-year change?
Over the past year, LAB quarterly selling, general & administrative expenses has changed by +$12.11 M (+54.33%)
What is Standard BioTools TTM selling, general & administrative expenses?
The current TTM SG&A of LAB is -$4.36 B
What is the all time high TTM SG&A for Standard BioTools?
Standard BioTools all-time high TTM selling, general & administrative expenses is $140.37 M
What is Standard BioTools TTM SG&A year-on-year change?
Over the past year, LAB TTM selling, general & administrative expenses has changed by -$4.44 B (-5140.90%)